Search

Search Constraints

You searched for: Author/Creator van Vollenhoven, R

Search Results

2. 059 A phase 3, randomised controlled trial comparing upadacitinib monotherapy to MTX monotherapy in MTX-naïve patients with active rheumatoid arthritis. (12th April 2019)

4. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. Issue 5 (8th May 2008)

5. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus. Issue 10 (5th September 2011)

6. Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort. (12th April 2016)

7. Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study. Issue 1 (10th May 2016)

9. Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists. Issue 1 (17th May 2016)